Provided by Tiger Trade Technology Pte. Ltd.

BriaCell Therapeutics Corp.

4.13
+0.14003.51%
Post-market: 4.04-0.0900-2.18%16:52 EST
Volume:121.98K
Turnover:493.60K
Market Cap:29.94M
PE:-0.12
High:4.15
Open:4.02
Low:3.95
Close:3.99
52wk High:98.20
52wk Low:3.67
Shares:7.25M
Float Shares:6.48M
Volume Ratio:0.56
T/O Rate:1.88%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-33.7856
EPS(LYR):-62.1862
ROE:-444.07%
ROA:-161.64%
PB:3.00
PE(LYR):-0.07

Loading ...

Jan 15, 2026

Major Issues Report

Form 8-K - Current report
Dec 29, 2025

Major Issues Report

Form 8-K - Current report
Dec 23, 2025

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Dec 23, 2025

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Dec 11, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 29, 2025

Major Issues Report

Form 8-K - Current report
Oct 16, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Aug 26, 2025

Major Issues Report

Form 8-K - Current report
Aug 01, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jul 16, 2025

Major Issues Report

Form 8-K - Current report
Jul 15, 2025

Correspondence

Form CORRESP - Correspondence
Jul 15, 2025

Correspondence

Form CORRESP - Correspondence
Jul 15, 2025

Correspondence

Form CORRESP - Correspondence
Jul 15, 2025

Correspondence

Form CORRESP - Correspondence
Jul 12, 2025

Correspondence

Form CORRESP - Correspondence
Jul 12, 2025

Correspondence

Form CORRESP - Correspondence
Jul 11, 2025

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Jul 10, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jul 09, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jul 09, 2025

Correspondence

Form CORRESP - Correspondence